Results 41 to 50 of about 2,031,844 (264)

Changes in PESI scores predict mortality in intermediate-risk patients with acute pulmonary embolism

, 2013
Although the Pulmonary Embolism Severity Index (PESI) accurately identifies 35% of patients with acute pulmonary embolism (PE) as being low risk, some patients deemed high risk by the PESI on admission might be treated safely in the outpatient ...
Gómez, Vicente, Aujesky, Drahomir, Jiménez, David, Instituto Ramón y Cajal de Investigación Sanitaria Pulmonary Emb,, García, Leticia, Yusen, Roger, Moores, Lisa, Zamarro, Celia, Nieto, Rosa   +8 more
core   +1 more source

Magnetic Micro‐ and Nanorobots for Precision Thrombolysis: Design Strategies and Translational Challenges

Advanced Robotics Research, EarlyView.
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin, Yimo Yan, Nikola Cesarovic, Simone Schuerle   +3 more
wiley   +1 more source

The Mind From Within: Visceral Roots of Human Cognition

Advanced Science, EarlyView.
The physiological activity of visceral organs, such as the heart, the lungs, and the gut, is surprisingly linked to many sophisticated mental operations, such as remembering the past, being aware of ourselves, making choices, and forging social bonds.
Alessandro Monti, Salvatore Maria Aglioti   +1 more
wiley   +1 more source

Extensive Pulmonary Embolism in late pregnancy associated with Anticardiolipin Antibodies [PDF]

, 2004
The leading cause of morbidity and mortality during pregnancy and the puerperium is venous thromboembolism. Though uncommon, the risk is five times higher in a pregnant woman than in a non-pregnant woman of similar age.1,2 In pregnancy, all three ...
Brincat, Mark P., Formosa, Mark, Buhagiar, Louis, Samuel, Anthony, Kunovski, Goce, Galea, David P.   +5 more
core  

No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial [PDF]

, 2010
Background Right ventricular dilatation in the setting of acute pulmonary embolism is associated with an adverse prognosis. Treatment with a pulmonary vasodilator has never been studied systematically.
Boonstra Anco B, Albertus J Kooter, Richard G IJzerman, Yvo M Smulders, Kamp Otto, Smulders Yvo M, Otto Kamp, Anco B Boonstra, Kooter, A.J., Kooter Albertus J, IJzerman, R.G., Boonstra, A., IJzerman Richard G, Kamp, O., Smulders, Y.M.   +14 more
core   +3 more sources

Membrane‐Active Peptide Protects Against Inflammation by Targeting NLRP3 Activation at the Trans‐Golgi Network

Advanced Science, EarlyView.
The membrane‐active peptide Pep19‐2.5 reduces harmful inflammation by blocking activation of the NLRP3 inflammasome at trans‐Golgi network membranes. By targeting key membrane interactions, Pep19‐2.5 suppresses inflammatory IL‐1β production and alleviates allergic airway inflammation in mice, leading to reduced immune cell infiltration and improved ...
Jonas Engelhardt, Nico Kirsch, Aileen Kerfin, Lars P. Lunding, Dominic Ferber, Hannes Buthmann, Ilka Schreier, Carlotta Bosio, Ann‐Kathrin Dobbelstein, Anna Klawonn, Rebecca C. Coll, Lena Bauernhofer, Sandro Keller, Matthias Geyer, Michael Wegmann, Andra B. Schromm, Günther Weindl   +16 more
wiley   +1 more source

Case Report: Successful revascularization in massive pulmonary embolism with a large protruding thrombus and dilated cardiomyopathy [version 2; peer review: 2 approved]

F1000Research, 2021
Pulmonary embolism is a potentially life-threatening condition. Despite advances in diagnostics, lack of consensus and delays in determining the diagnosis of pulmonary embolism are still important problems.
Hendri Susilo, Rerdin Julario, Citrawati Dyah Kencono Wungu   +2 more
doaj   +1 more source

Management of pulmonary embolism

, 2022
Pulmonary embolism is a serious medical condition that can lead to death. Pulmonary embolism is blockage of the pulmonary artery by emboli. Dyspnea, chest pain, cough and hemoptysis are the main clinical symptoms and signs of pulmonary embolism.
Kim, Woosung
core  

Versatile Co‐Engineering of Immunogenic Cell Death‐Primed Dead Tumor Cell Bodies With Tumor‐Activated MnO2 for cGAS‐STING‐Potentiated Personalized Immunotherapy

Advanced Science, EarlyView.
DTBEI@CS@MnO2, fabricated via modular electrostatic co‐engineering and photothermal/photodynamic immunogenic cell death, specifically responds to the acidic and GSH‐rich tumor microenvironment. This triggers the release of DTBEI that provides tumor antigens, DNA, and DAMPs, as well as the generation of Mn2+, thereby synergistically potentiating cGAS ...
Bolun Xu, Xuan Lu, Yuquan Wang, Haihua Ji, Ying Zhang, Yiqun Wan, Hao Wan   +6 more
wiley   +1 more source

Short-term results of the pulmonary embolism treatment

Zaporožskij Medicinskij Žurnal, 2015
Aim. Acute pulmonary embolism (PE) is a common and often fatal disease with the level of mortality in the acute phase from 7 to 11%. In order to develop indications to thrombolytic therapy the short-term results of treatment with the use of combination ...
A. S. Nikonenko , A. A. Nikonenko, S. A. Matvieiev   +2 more
doaj   +1 more source